Bausch Health Companies Inc. Deferred Income Tax Liabilities, Net
Bausch Health Companies Inc. (BHC) had Deferred Income Tax Liabilities, Net of $211.00 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-07-30
- 2026-06-30: Deferred Income Tax Liabilities, Net $211.00M.
- 2026-03-31: Deferred Income Tax Liabilities, Net $179.00M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $147.00M.
- 2025-09-30: Deferred Income Tax Liabilities, Net $145.00M.
| Period end | Deferred Income Tax Liabilities, Net | Deferred Income Tax Liabilities, Net as first filed |
|---|---|---|
| 2026-06-30 | $211.00M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $179.00M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $147.00M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $145.00M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $144.00M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $134.00M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $128.00M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $169.00M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $170.00M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $170.00M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $163.00M 10-K · filed 2025-02-20 | |
| 2023-09-30 | $213.00M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $215.00M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $205.00M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $202.00M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $422.00M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $545.00M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $552.00M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $529.00M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $513.00M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $516.00M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $520.00M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $528.00M 8-K · filed 2022-05-11 | |
| 2020-09-30 | $650.00M 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $694.00M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $690.00M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $705.00M 8-K · filed 2021-05-04 | |
| 2019-09-30 | $879.00M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $884.00M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $880.00M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $885.00M 10-K · filed 2020-02-19 | |
| 2018-09-30 | $1.13B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.13B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $1.03B 10-Q · filed 2019-05-06 | $1.14B 10-Q · filed 2018-05-08 |
| 2017-12-31 | $1.18B 10-K · filed 2019-02-20 | |
| 2017-09-30 | $2.24B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $4.27B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $4.49B 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $5.43B 8-K · filed 2018-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |